Class information for:
Level 1: LOWER URINARY TRACT SYMPTOMS//BENIGN PROSTATIC HYPERPLASIA//LUTS

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
714 3070 29.6 76%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
157 21931 BENIGN PROSTATIC HYPERPLASIA//PROSTATE CANCER//PROSTATE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LOWER URINARY TRACT SYMPTOMS Author keyword 340 48% 17% 513
2 BENIGN PROSTATIC HYPERPLASIA Author keyword 290 32% 25% 755
3 LUTS Author keyword 124 49% 6% 184
4 TAMSULOSIN Author keyword 98 45% 5% 166
5 PROSTATIC HYPERPLASIA Author keyword 97 32% 8% 250
6 ALFUZOSIN Author keyword 83 63% 3% 85
7 BPH Author keyword 71 28% 7% 216
8 TRIAL WITHOUT CATHETER Author keyword 52 100% 1% 18
9 INTERNATIONAL PROSTATE SYMPTOM SCORE Author keyword 51 66% 2% 48
10 SILODOSIN Author keyword 41 63% 1% 41

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 LOWER URINARY TRACT SYMPTOMS 340 48% 17% 513 Search LOWER+URINARY+TRACT+SYMPTOMS Search LOWER+URINARY+TRACT+SYMPTOMS
2 BENIGN PROSTATIC HYPERPLASIA 290 32% 25% 755 Search BENIGN+PROSTATIC+HYPERPLASIA Search BENIGN+PROSTATIC+HYPERPLASIA
3 LUTS 124 49% 6% 184 Search LUTS Search LUTS
4 TAMSULOSIN 98 45% 5% 166 Search TAMSULOSIN Search TAMSULOSIN
5 PROSTATIC HYPERPLASIA 97 32% 8% 250 Search PROSTATIC+HYPERPLASIA Search PROSTATIC+HYPERPLASIA
6 ALFUZOSIN 83 63% 3% 85 Search ALFUZOSIN Search ALFUZOSIN
7 BPH 71 28% 7% 216 Search BPH Search BPH
8 TRIAL WITHOUT CATHETER 52 100% 1% 18 Search TRIAL+WITHOUT+CATHETER Search TRIAL+WITHOUT+CATHETER
9 INTERNATIONAL PROSTATE SYMPTOM SCORE 51 66% 2% 48 Search INTERNATIONAL+PROSTATE+SYMPTOM+SCORE Search INTERNATIONAL+PROSTATE+SYMPTOM+SCORE
10 SILODOSIN 41 63% 1% 41 Search SILODOSIN Search SILODOSIN

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BENIGN PROSTATIC HYPERPLASIA 262 26% 28% 866
2 URINARY TRACT SYMPTOMS 232 32% 20% 611
3 SELECTIVE ALPHA1A ADRENOCEPTOR ANTAGONIST 153 89% 2% 68
4 TAMSULOSIN 133 43% 8% 235
5 TERAZOSIN 132 56% 5% 160
6 FINASTERIDE 125 27% 13% 391
7 ALFUZOSIN 86 58% 3% 99
8 DOXAZOSIN 83 40% 5% 166
9 OBSTRUCTION SYMPTOMATIC BPH 82 86% 1% 42
10 BPH 77 42% 5% 141

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LUTS-LOWER URINARY TRACT SYMPTOMS 5 15% 1% 34
2 INTERNATIONAL NEUROUROLOGY JOURNAL 2 13% 0% 15

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis 2015 8 45 71%
A Systematic Review and Meta-analysis on the Use of Phosphodiesterase 5 Inhibitors Alone or in Combination with alpha-Blockers for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia 2012 70 39 82%
Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK 2015 2 42 83%
Impact of Medical Treatments for Male Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia on Ejaculatory Function: A Systematic Review and Meta-Analysis 2014 8 42 90%
Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard? 2014 8 50 82%
The Mechanism of Action of Phosphodiesterase Type 5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia 2013 26 61 61%
Critical Analysis of the Relationship Between Sexual Dysfunctions and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia 2011 60 122 64%
Systematic Review of Combination Drug Therapy for Non-neurogenic Male Lower Urinary Tract Symptoms 2013 19 68 76%
A meta-analysis on the efficacy and tolerability of alpha(1)-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction 1999 221 57 84%
Lifestyle factors, benign prostatic hyperplasia, and lower urinary tract symptoms 2011 29 29 100%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BLADDER PROSTATE HLTH 13 67% 0.4% 12
2 INTER FUNCT CELLULAR PHARMACOL REPROD 6 39% 0.4% 12
3 MINIMAL INVAS UROL 4 75% 0.1% 3
4 SEXUAL MED ANDROL UNIT 4 17% 0.6% 19
5 PHARMACOEPIDEMIOL PUBL HLTH 3 57% 0.1% 4
6 COCHRANE REVIEW GRP PROSTATE DIS UROL CANC 3 60% 0.1% 3
7 ONCOL SURG GASTROENTEROL SCI 3 60% 0.1% 3
8 UROL EPIDEMIOL 2 44% 0.1% 4
9 GLOBAL MED OUTCOMES 2 67% 0.1% 2
10 SUN YET SUN MEM HOSP 2 67% 0.1% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000254274 HUHS1015//CHRONIC PROSTATIC INFLAMMATION//NAFTOPIDIL
2 0.0000204725 D 004//PC SPES//SERENOA REPENS
3 0.0000177945 URODYNAMICS//PRESSURE FLOW STUDY//UROFLOWMETRY
4 0.0000165813 TRANSURETHRAL RESECTION OF PROSTATE//ELECTROVAPORIZATION//PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE
5 0.0000161341 NOCTURIA//NOCTURNAL POLYURIA//DESMOPRESSIN
6 0.0000132400 PROSTATIC ARTERY EMBOLIZATION//UNIV ANAT//PROSTATIC ARTERIAL EMBOLIZATION
7 0.0000127238 ALPHA1 ADRENOCEPTOR SUBTYPE//CHLOROETHYLCLONIDINE//ALPHA1B ADRENOCEPTOR
8 0.0000108524 5 ALPHA REDUCTASE//FINASTERIDE//BIOL SYST ANIM PROD
9 0.0000104074 DOXAZOSIN MESYLATE//SELECTIVE ALPHA1 BLOCKERS//ALFUZOSIN HYDROCHLORIDE
10 0.0000095045 PEROPERATIVE BLEEDING//PRIMARY PROSTATE CULTURE//BLOOD VESSEL MORPHOLOGY